Kenta Biotech AG
  • Home
  • Shop
  • Events
  • Courses
  • Services
  • Pricing
  • Company
    • News
    • Success Stories
    • About Us
  • Appointment
  • Contact us
  • 0
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
Kenta Biotech AG
  • 0
    • Home
    • Shop
    • Events
    • Courses
    • Services
    • Pricing
    • Company
      • News
      • Success Stories
      • About Us
    • Appointment
    • Contact us
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
  1. Products
  2. Assay test kits
Public Pricelist
Public Pricelist
Sort By: Featured
Featured Newest Arrivals Name (A-Z) Price - Low to High Price - High to Low

Assay test kits

[0203-414152F-500T] Histofine Simple Stain Human MAX PO (MULTI) (for Mouse & Rabbit primary antibody) - 500 Tests
Histofine Simple Stain Human MAX PO (MULTI) (for Mouse & Rabbit primary antibody) - 500 Tests
717.24 € 717.24 EUR
[0444-HV02-922N] HemaVision® -9;22N | HV02-922N, 25 tests
HemaVision® -9;22N | HV02-922N, 25 tests
1,431.30 € 1431.3 EUR
[0444-HV02-1517N] HemaVision® -15;17N | HV02-1517N, 25 tests
HemaVision® -15;17N | HV02-1517N, 25 tests
1,431.30 € 1431.3 EUR
[0198-KLHG-20] HUMAN ANTI-KLH IGG ELISA, 96 tests
HUMAN ANTI-KLH IGG ELISA, 96 tests
800.00 € 800.0 EUR
[0563-CTK-R0213C] HSV2 IgG/IgM Rapid Test - 30 Tests/Test
HSV2 IgG/IgM Rapid Test - 30 Tests/Test
320.00 € 320.0 EUR
[0563-CTK-R0203C] HSV-1 IgG/IgM Rapid Test CE, 30 tests/Test
HSV-1 IgG/IgM Rapid Test CE, 30 tests/Test
264.00 € 264.0 EUR
[0544-MBS040244-96T] HS-CRP elisa Test :: Human High Sensitivity C-Reactive Protein ELISA Test - 96 Tests
HS-CRP elisa Test :: Human High Sensitivity C-Reactive Protein ELISA Test - 96 Tests
1,054.00 € 1054.0 EUR
[0563-CTK-R0038C] HIV/Syphilis/HBV/HCV Panel Rapid Test - 20 tests
HIV/Syphilis/HBV/HCV Panel Rapid Test - 20 tests
320.00 € 320.0 EUR
[0563-CTK-R0035C] HIV/Syphilis Ab Combo Rapid Test, 30 tests/Test
HIV/Syphilis Ab Combo Rapid Test, 30 tests/Test
135.00 € 135.0 EUR
[0173-AF03FK10CE] HIV 1/2 3.0 CE(D) 30T_GLOBAL  - 30 tests/Test
HIV 1/2 3.0 CE(D) 30T_GLOBAL - 30 tests/Test
166.00 € 166.0 EUR
[0544-MBS9333725] HEPACAM elisa Test :: Human hepatocyte cell adhesion molecule ELISA Test - 96 Tests
HEPACAM elisa Test :: Human hepatocyte cell adhesion molecule ELISA Test - 96 Tests
1,054.00 € 1054.0 EUR
[0441-V3-100/2FRT-100] HDV Real-TM Quant - 100 Tests
HDV Real-TM Quant - 100 Tests
2,170.00 € 2170.0 EUR
[0826-ABT-IDT-A11] HCV Strip (Serum/Plasma), 50 tests
HCV Strip (Serum/Plasma), 50 tests
90.00 € 90.0 EUR
[0441-V1-100/2FRT] HCV Real-TM Quant - 100 Tests
HCV Real-TM Quant - 100 Tests
984.50 € 984.5 EUR
[0826-ABT-IDT-B11] HCV Cassette (Serum/Plasma), 25 tests/pack
HCV Cassette (Serum/Plasma), 25 tests/pack
60.00 € 60.0 EUR
[0563-CTK-R0024C] HCV Ab Plus Combo Rapid Test, 30 tests/Test
HCV Ab Plus Combo Rapid Test, 30 tests/Test
133.00 € 133.0 EUR
[0563-CTK-R0028C] HBsAg/HCV Ab Rapid Test, 30 tests
HBsAg/HCV Ab Rapid Test, 30 tests
133.00 € 133.0 EUR
[0563-R0042C] HBsAg Combo Rapid Test - 30 tests/Test
HBsAg Combo Rapid Test - 30 tests/Test
366.60 € 366.6 EUR
[0563-CTK-R0049C] HBV-5 Rapid Test - 20 tests/Test
HBV-5 Rapid Test - 20 tests/Test
320.00 € 320.0 EUR
[0441-V5-100/2FRT-100] HBV Real-TM Quant  - 100 Tests
HBV Real-TM Quant - 100 Tests
2,175.00 € 2175.0 EUR
  • 7
  • 8
  • 9
  • 10
  • 11

Clear Filters



Respiratory syncytial virus (RSV) infections are the most common cause of hospitalization in early childhood, accounting for 57 000 to 120 000 hospitalizations each year in the United States. RSV is causing annual epidemics of bronchiolitis and pneumonia worldwide. In most cases the infection with RSV heals without sequelae, yet RSV infection can cause lung function deterioration and in some circumstances, years of recurrent wheezing or asthma may ensue. Overall RSV accounts for an estimated2% of the hospitalization rate among infants less than 1 year of age. This rate increases 4–5-fold among high-risk patients such as premature infants and those with chronic lung disease or complicated congenital heart disease.


Currently there is only one possibility to prevent infections of at-risk patients with RSV, namely immuno-prophylaxis with palivizumab/Synagis, marketed by MedImmune. However, the response to palivizumab is variable among individuals, and sometimes palivizumab fails to prevent RSV infections effectively.


Due to the lack of better antibodies, lack of effective anti-viral treatment and lack of an effective preventive vaccine for RSV, there is a substantial medical need for more efficacious prophylactic immunizations, e.g. by antibody.


Kenta Biotech had developed a fully human monoclonal antibody (KBRV201) derived from B-cells of a human donor. KBRV201 is of the human IgG1 isotype with specificity and very high affinity for the F-protein of human respiratory syncytial virus (hRSV). KBRV201 has been tested for recognition and neutralization of hRSV strains -A, -B and –Long, and KBRV201 could neutralize in vitro all strains tested with higher efficacy than other anti-F-protein mAb.




KBRV201 successfully recognizes 22 clinical isolates from children infected with RSV, including one isolate with a mutated F-protein. Overall KBRV201 has demonstrated superiority in every experiment performed, and KBRV201 is currently undergoing extensive testing in animal models.

14009 NW Harbor Ln, Portland, OR 97229, USA.


Follow us
Copyright © 2025 Kenta Biotech AG
English (UK) English (US)